Netherlands-based ScreenPoint Medical has acquired Biomediq A/S, the Danish developer of mammogram analysis technology, to advance the capabilities of its AI-powered Transpara: Breast AI screening ...

Gastounioti The National Cancer Institute, part of the National Institutes of Health (NIH), has awarded Aimilia Gastounioti a ...

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result ...

A recent study suggests that a simple blood test measuring epigenetic aging could help predict breast cancer risk in older ...

To better tailor screening decisions for women 40-49 years old, Kerlikowske uses the Breast Cancer Surveillance Consortium ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...

Hall shared her story on "CBS Mornings," explaining how Munn's advocacy for early detection, along with a breast cancer risk assessment tool, led to her life-saving diagnosis. Munn credited the ...

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

Winnipeg-born reporter Alison Hall was diagnosed with breast cancer after covering actress Olivia Munn’s diagnosis. Hall, 33, ...

“These findings further support Myriad’s commitment to provider ease of use and patient access by enabling an always-on tool to drive appropriate patient identification and education, via our Breast ...

The Transpara tool has been clinically proven to ... of Transpara to improve performance for mammography-based breast cancer risk assessment. This is a game-changing step in providing accurate ...